Arrivo BioVentures today announced positive data from its SP-624-103 study evaluating the impact of SP-624's novel epigenetic mechanism of action on neurological pathways. The findings provide ...

ORLADEYO net revenue expected to be between $515-$535 million in 2025— —Total revenue (including RAPIVAB®) expected to be ...

Meridian Waste North Carolina, LLC announces the asset acquisition of Foothills Waste Solutions, LLC effective January 1, ...

Toshiba and Qualcomm are collaborating to bring advanced, scalable AI-powered IoT solutions to the retail industry.

Ancient Viral DNA in the Human Genome Linked to Multiple Sclerosis and Amyotrophic Lateral Sclerosis Oct. 21, 2024 — New research has revealed a connection between ancient viral DNA embedded in ...

Following a fresh round of job cuts in December, CDMO National Resilience is carrying its downsizing efforts into 2025. | ...

D.R. Horton (NYSE: DHI) recently paid $4.475 million for an office building on Meridian Parkway near Research Triangle Park, ...

National Resilience acquired the Triangle office in 2021. Since then, funding for gene therapy solutions has fallen.

National Reliance Inc., which focuses on biologics, vaccines, and gene therapies, is expected to keep the Triangle office open after the cuts.

RESEARCH TRIANGLE PARK, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the 43rd Annual J.P. Morgan Healthcare ...